119 related articles for article (PubMed ID: 1631178)
1. Effect of adenosine analogues on the expression of opiate withdrawal in rats.
Dionyssopoulos T; Hope W; Coupar IM
Pharmacol Biochem Behav; 1992 Jun; 42(2):201-6. PubMed ID: 1631178
[TBL] [Abstract][Full Text] [Related]
2. Withdrawal and bidirectional cross-withdrawal responses in rats treated with adenosine agonists and morphine.
Coupar IM; Tran BL
Life Sci; 2001 Jul; 69(7):779-90. PubMed ID: 11487090
[TBL] [Abstract][Full Text] [Related]
3. Effects of adenosine receptor agents on the expression of morphine withdrawal in mice.
Zarrindast MR; Naghipour B; Roushan-zamir F; Shafaghi B
Eur J Pharmacol; 1999 Mar; 369(1):17-22. PubMed ID: 10204676
[TBL] [Abstract][Full Text] [Related]
4. Effect of alpha 2-adrenoceptor agonists on the expression of morphine-withdrawal in rats.
Coupar IM
Naunyn Schmiedebergs Arch Pharmacol; 1992 May; 345(5):553-7. PubMed ID: 1356234
[TBL] [Abstract][Full Text] [Related]
5. Dorsal and median raphe serotonergic system lesion does not alter the opiate withdrawal syndrome.
Caillé S; Espejo EF; Koob GF; Stinus L
Pharmacol Biochem Behav; 2002 Jul; 72(4):979-86. PubMed ID: 12062589
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by adenosine analogs of opiate withdrawal effects.
Tucker JF; Plant NT; von Uexküll A; Collier HO
NIDA Res Monogr; 1984 Mar; 49():85-91. PubMed ID: 6090921
[TBL] [Abstract][Full Text] [Related]
7. Adenosine receptor agonists attenuate and adenosine receptor antagonists exacerbate opiate withdrawal signs.
Kaplan GB; Sears MT
Psychopharmacology (Berl); 1996 Jan; 123(1):64-70. PubMed ID: 8741956
[TBL] [Abstract][Full Text] [Related]
8. Effect of adenosine receptor agonists and antagonists on the expression of opiate withdrawal in rats.
Salem A; Hope W
Pharmacol Biochem Behav; 1997 Aug; 57(4):671-9. PubMed ID: 9258993
[TBL] [Abstract][Full Text] [Related]
9. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal.
Caillé S; Espejo EF; Reneric JP; Cador M; Koob GF; Stinus L
J Pharmacol Exp Ther; 1999 Aug; 290(2):881-92. PubMed ID: 10411605
[TBL] [Abstract][Full Text] [Related]
10. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
Lichtman AH; Sheikh SM; Loh HH; Martin BR
J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of lofexidine in blocking morphine-withdrawal signs in the rat.
Shearman GT; Lal H; Ursillo RC
Pharmacol Biochem Behav; 1980 Apr; 12(4):573-5. PubMed ID: 7190295
[TBL] [Abstract][Full Text] [Related]
12. Identification of A1 and A2 adenosine receptors in the rat spinal cord.
Choca JI; Proudfit HK; Green RD
J Pharmacol Exp Ther; 1987 Sep; 242(3):905-10. PubMed ID: 3656118
[TBL] [Abstract][Full Text] [Related]
13. Blocking naloxone-precipitated withdrawal in rats and hamsters.
Schnur P; Espinoza M; Flores R; Ortiz S; Vallejos S; Wainwright M
Pharmacol Biochem Behav; 1992 Dec; 43(4):1093-8. PubMed ID: 1475293
[TBL] [Abstract][Full Text] [Related]
14. Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal.
Taylor JR; Elsworth JD; Garcia EJ; Grant SJ; Roth RH; Redmond DE
Psychopharmacology (Berl); 1988; 96(1):121-34. PubMed ID: 3147472
[TBL] [Abstract][Full Text] [Related]
15. Effect of nimodipine, diltiazem and BAY K 8644 on the behavioural and neurochemical changes associated with naloxone-precipitated withdrawal in the rat. A comparison with clonidine.
Colado MI; Alfaro MJ; Lopez F; Del Val V; Martin MI
Gen Pharmacol; 1993 Jan; 24(1):35-41. PubMed ID: 7683298
[TBL] [Abstract][Full Text] [Related]
16. alpha N-acetyl human beta-endorphin-(1-31) alleviates the morphine withdrawal syndrome in rodents: a comparative study with clonidine.
Garzón J; Sánchez-Blázquez P
Life Sci; 1992; 50(26):2099-109. PubMed ID: 1608292
[TBL] [Abstract][Full Text] [Related]
17. Clonidine attenuates conditioned aversion produced by naloxone-precipitated opiate withdrawal.
Kosten TA
Eur J Pharmacol; 1994 Mar; 254(1-2):59-63. PubMed ID: 8206117
[TBL] [Abstract][Full Text] [Related]
18. Alterations of adenosine A1 receptors in morphine dependence.
Kaplan GB; Leite-Morris KA; Sears MT
Brain Res; 1994 Sep; 657(1-2):347-50. PubMed ID: 7820640
[TBL] [Abstract][Full Text] [Related]
19. Effects induced by BC 264, a selective agonist of CCK-B receptors, on morphine-dependent rats.
Maldonado R; Valverde O; Derrien M; Tejedor-Real P; Roques BP
Pharmacol Biochem Behav; 1994 Jun; 48(2):363-9. PubMed ID: 8090802
[TBL] [Abstract][Full Text] [Related]
20. Clonidine but not nifedipine prevents the release of noradrenaline during naloxone-precipitated opiate withdrawal: an in vivo microdialysis study in the rat.
Silverstone PH; Done C; Sharp T
Psychopharmacology (Berl); 1992; 109(1-2):235-8. PubMed ID: 1365663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
